News

India has set a massive effort to reduce its reliance on China for crucial raw materials as part of its drive to become the world's "pharmacy." India, which is already the world's third-largest producer of drugs by quantity, has one...

While the COVID-19 outbreak prompted the development of novel antibody medicines and vaccinations, scientists have discovered that current medications can occasionally aid patients in their fight against the virus. A clinically meaningful trial on rheumatoid arthritis medicines in hospitalised...

In a deal worth up to $3.3 billion, GlaxoSmithKline (GSK) has reached a formal agreement to buy 100% of the outstanding shares of Affinivax, a clinical-stage biopharmaceutical company based in the United States. GSK will make an initial payment...

Peli BioThermal, the life science industry’s partner from discovery to distribution, recently concluded its InnovationShare webinar series. Launched in March 2021, InnovationShare was designed to fill the in-person learning gap during the height of the COVID-19 pandemic. Webinars brought...

Memo Therapeutics has brought to notice the start of a clinical trial in renal transplant patients to treat BK polyomavirus (BKV) infection.The safety, tolerability, and pharmacokinetics of MTX-005 will be assessed in a phase 1 single-blind, partially randomised, and placebo-controlled...

Jubilant HollisterStier has grabbed a $146.6 million contract from the US government, continuing to ride the industrial expansion wave created by the COVID-19 business boom. The contract, which was signed with numerous agencies of the Department of Health and...

Sandoz, a biosimilars manufacturer, has announced the beginning of a new global campaign to combat global health disparities. By harnessing the '4 As' of biosimilars- approval, accessibility, acceptability, and affordability, Act4Biosimilars strives to expand patient access to innovative treatments....